You are here

diabetes

Roche buys mySugr diabetes app

Drug Delivery Business News

Sat, 07/1/17 - 09:23 am

MannKind: Afrezza Sales See Best Result In More Than A Year

Seeking Alpha

Mon, 06/26/17 - 11:49 am

inhaled insulin

Medtronic inks diabetes deal with Aetna

Mass Device

Mon, 06/26/17 - 09:55 am

For diabetes drugs, lowering blood sugar may no longer be enough to stay competitive

Medical Marketing and Media

Thu, 06/22/17 - 09:32 am

FDA panel supports cardiovascular indication for Novo’s diabetes drug Victoza

Fierce Pharma

Tue, 06/20/17 - 10:53 pm

advisory panels

Novo Nordisk files to add Lantus-matching CV data to Tresiba's European label

Fierce Pharma

Fri, 06/16/17 - 09:35 am

MannKind’s Afrezza needs a big turn. Can reality TV and a new commercial get it done?

Fierce Pharma

Thu, 06/15/17 - 05:15 pm

Lilly wins FDA nod for Humalog pre-filled Junior KwikPen device

Drug Delivery Business News

Wed, 06/14/17 - 09:05 pm

AstraZeneca, Boehringer cry 'no class effect' after Johnson & Johnson's Invokana doubles amputations in study

Fierce Pharma

Wed, 06/14/17 - 09:00 pm

Boehringer Ingelheim

J&J's Invokana lowers CV risk, but by enough to compete?

BioPharma Dive

Wed, 06/14/17 - 11:37 am

Boehringer Ingelheim

ADA 2017 Roundup: J&J inks dev deal with Qualcomm, launches next-gen OneTouch Reveal app

Mass Device

Tue, 06/13/17 - 04:14 pm

OneTouch Vario Flex

blood glucose monitoring

MannKind Scripts Not Helping Cash Situation

Seeking Alpha

Tue, 06/13/17 - 04:13 pm

inhaled insulin

ADA: Merck, Pfizer notch success, but late with SGLT-2 data

BioPharma Dive

Tue, 06/13/17 - 12:15 pm

SGLT2 inhibitor

Boehringer Ingelheim

J&J Drug Prevents Heart Attacks At Cost Of Amputated Toes

Forbes

Mon, 06/12/17 - 10:15 pm

amputation. Eli Lilly

Boehringer Ingelheim

Sanofi and Regeneron's Praluent safely smacks LDL in high-risk diabetics

Fierce Pharma

Mon, 06/12/17 - 09:42 am

LDL cholesterol

Novo's Xultophy beats basal-bolus insulin at cutting hypoglycemia, spurring weight loss

Fierce Pharma

Sun, 06/11/17 - 05:08 pm

ADA preview: 5 things to watch in diabetes

BioPharma Dive

Sun, 06/11/17 - 09:30 am

Boehringer Ingelheim

PCSK9 inhibitors

Amgen Regeneron

Merck, Pfizer trot out more support for latecomer SGLT2 candidate ertugliflozin

Fierce Pharma

Sun, 06/11/17 - 09:24 am

Why Novo Nordisk A/S (ADR) Jumped 10.6% In May

Motley Fool

Sun, 06/11/17 - 09:13 am

Lexicon diabetes pill hits endpoint in another phase 3, teeing up regulatory filings by partner Sanofi

Fierce Biotech

Fri, 06/9/17 - 11:02 am

Lexicon Pharmaceuticals

clinical trials

Pages